Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2746-2753
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2746
Figure 1
Figure 1 Flow diagram comparing switching to tenofovir disoproxil fumarate monotherapy and continued lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients with a suboptimal response to lamivudine plus adefovir. LAM: Lamivudine; ADV: Adefovir; TDF: Tenofovir disoproxil fumarate.